(19)
(11) EP 2 705 021 A2

(12)

(88) Date of publication A3:
21.03.2013

(43) Date of publication:
12.03.2014 Bulletin 2014/11

(21) Application number: 12766333.4

(22) Date of filing: 04.05.2012
(51) International Patent Classification (IPC): 
C07C 211/42(2006.01)
C07C 309/35(2006.01)
C07C 309/29(2006.01)
(86) International application number:
PCT/IN2012/000329
(87) International publication number:
WO 2012/153349 (15.11.2012 Gazette 2012/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 04.05.2011 IN MM13822011
09.11.2011 IN MM31692011

(71) Applicant: Cadila Healthcare Limited
Ahmedabad 380 015, Gujarat (IN)

(72) Inventors:
  • DWIVEDI, Shriprakash, Dhar
    Ahmedabad 380015, Gujarat (IN)
  • PRASAD, Ashok
    Ahmedabad 380015, Gujarat (IN)
  • PATEL, Mayur, Ramnikbhai
    Ahmedabad 380015, Gujarat (IN)

(74) Representative: Jones, Helen M.M. 
Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street
London EC2A 2ES
London EC2A 2ES (GB)

   


(54) RASAGILINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS